SC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?

The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug Risdiplam affordable in India. The move comes after it was reported that the drug is much cheaper in Pakistan and China due to government interventions.
|
||||||
💡 newsR Knowledge: Other News Mentions
|
![]()
China -Taiwan Rift: Fire Drills target Taiwan in East China Sea|U.S Reacts to threat posed by China
Credit: Oneindia Duration: 03:04Published
|
![]()
Trump's ‘Liberation Day' – Trade War Begins! India, China, EU Brace for Immediate Economic Attack
Credit: Oneindia Duration: 03:14Published
|
![]()
Jammu and Kashmir: 3 Terrorists Trapped in Kathua as Gunfight Erupts, 2nd Encounter in 3 Days
Credit: Oneindia Duration: 03:05Published
|